

"Specialist preclinical CRO delivering expert ion channel and cardiac safety screening services"
Metrion Biosciences is a contract research organisation specialising in preclinical drug discovery services for pharmaceutical and biotech companies. The company provides expert ion channel screening, cardiac safety profiling, and neuroscience assays using advanced electrophysiology platforms. Their services support the full drug discovery cycle, from assay development through lead optimisation. Founded in 2015 at Granta Park in Cambridge, Metrion operates laboratories with automated and manual patch clamp systems, stem cell facilities, and high throughput screening platforms. Their team delivers decision ready data that helps researchers advance compounds through development with confidence and regulatory compliance.


40
Team Members
2015
Founded
Contract Research
Sector
On-Site
Work Environment
A pharmaceutical industry where every drug candidate is evaluated with precision electrophysiology data, enabling safer and more effective medicines to reach patients faster.
To deliver specialist advice and expertise, high quality preclinical data and outstanding customer service, empowering the success of pharmaceutical research and development.